SITO Mobile to Present at Craig-Hallum’s 7th Annual Alpha Select Conference
Nov 04, 2016 12:00 pm UTC| Business
JERSEY CITY, N.J., Nov. 04, 2016 -- SITO Mobile Ltd. (Nasdaq:SITO), a leading mobile engagement platform provider, announced today that Jerry Hug, SITO’s CEO, will be presenting on behalf of the company at the...
Nov 04, 2016 12:00 pm UTC| Business
YAVNE, Israel, Nov. 04, 2016 -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announces that...
Bio-Path Holdings to Present Data at the 2016 ASH Annual Meeting
Nov 04, 2016 12:00 pm UTC| Business
HOUSTON, Nov. 04, 2016 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
Carbonite to Present at the UBS Global Technology Conference on Tuesday November 15th, 2016
Nov 04, 2016 12:00 pm UTC| Business
BOSTON, Nov. 04, 2016 -- Carbonite, Inc. (NASDAQ:CARB) a leading provider of cloud backup and restore solutions for small and mid-sized businesses (SMBs) today announced its upcoming participation at the UBS Global...
Windstream declares 15-cent quarterly dividend
Nov 04, 2016 11:30 am UTC| Business
LITTLE ROCK, Ark., Nov. 04, 2016 -- The board of directors of Windstream Holdings, Inc. (NASDAQ:WIN) today declared a quarterly dividend of 15 cents per share on the company’s common stock. The dividend is payable...
MoSys, Inc. Reports Third Quarter 2016 Financial Results
Nov 04, 2016 11:30 am UTC| Business
SANTA CLARA, Calif., Nov. 04, 2016 -- MoSys, Inc. (NASDAQ:MOSY), a leader in semiconductor solutions that enable fast, intelligent data access for Cloud, network, and communications systems, today reported financial...
Nov 04, 2016 11:30 am UTC| Business
LA JOLLA, Calif., Nov. 04, 2016 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today presented preclinical findings and data from the company’s ongoing Phase 2 trial in HRAS mutant...